Patients with myocardial infarction, which does not include all layers of the heart's muscle
wall are common and they often receive pharmacological treatment with the platelet inhibiting
drug ticagrelor. However, the drug uptake after an oral dose of 180mg ticagrelor has not been
thoroughly studied in these patients.
The present study will evaluate ticagrelor uptake and platelet aggregation after a 180 mg
loading dose ticagrelor in these patients.